These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2268489)
21. Relapsing peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis due to Corynebacterium aquaticum. Morris AJ; Henderson GK; Bremner DA; Collins JF J Infect; 1986 Sep; 13(2):151-6. PubMed ID: 3489789 [TBL] [Abstract][Full Text] [Related]
22. Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoneal dialysis patients: relationship to peritoneal transport of solutes. Kagan A; Bar-Khayim Y Nephron; 1995; 71(3):314-20. PubMed ID: 8569981 [TBL] [Abstract][Full Text] [Related]
23. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD. Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278 [TBL] [Abstract][Full Text] [Related]
24. Protein losses and tobramycin absorption in peritonitis treated by hourly peritoneal dialysis. Rubin J; Deraps GD; Walsh D; Adair C; Bower J Am J Kidney Dis; 1986 Aug; 8(2):124-7. PubMed ID: 3740060 [TBL] [Abstract][Full Text] [Related]
28. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Gordon DL; Rice JL; Avery VM Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088 [TBL] [Abstract][Full Text] [Related]
29. Fluid transport in peritoneal dialysis. Lindholm B; Werynski A; Bergström J Int J Artif Organs; 1990 Jun; 13(6):352-8. PubMed ID: 2379969 [TBL] [Abstract][Full Text] [Related]
30. Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients: a multicenter study. De Vecchi AF; Kopple JD; Young GA; Nolph KD; Vonesh EF; Castelnovo C; Dichiro J; Nissenson A; Brownjohn AM; Prowant B Am J Nephrol; 1990; 10(6):451-6. PubMed ID: 2075902 [TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis. Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099 [TBL] [Abstract][Full Text] [Related]
32. High peritoneal residual volume decreases the efficiency of peritoneal dialysis. Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469 [TBL] [Abstract][Full Text] [Related]
33. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Rubin J; Ray R; Barnes T; Bower J Nephron; 1981; 29(3-4):124-7. PubMed ID: 7329486 [TBL] [Abstract][Full Text] [Related]
34. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis? Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267 [TBL] [Abstract][Full Text] [Related]
36. A fast reliable method for the measurement of intraperitoneal dextran 70, used to calculate lymphatic absorption. Koomen GC; Krediet RT; Leegwater AC; Struijk DG; Arisz L; Hoek FJ Adv Perit Dial; 1991; 7():10-4. PubMed ID: 1716991 [TBL] [Abstract][Full Text] [Related]
37. Intraperitoneal flucytosine in the management of fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eisenberg ES Am J Kidney Dis; 1988 Jun; 11(6):465-7. PubMed ID: 3376930 [TBL] [Abstract][Full Text] [Related]
38. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
39. Lymphatic drainage of hypertonic solution from peritoneal cavity of anesthetized and conscious sheep. Tran L; Rodela H; Abernethy NJ; Yuan ZY; Hay JB; Oreopoulos D; Johnston MG J Appl Physiol (1985); 1993 Feb; 74(2):859-67. PubMed ID: 8458807 [TBL] [Abstract][Full Text] [Related]
40. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Zemel D; Imholz AL; de Waart DR; Dinkla C; Struijk DG; Krediet RT Kidney Int; 1994 Nov; 46(5):1422-30. PubMed ID: 7853803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]